{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:26:25Z","timestamp":1791822385630,"version":"4.3.4"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,9]],"date-time":"2024-11-09T00:00:00Z","timestamp":1731110400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,9]],"date-time":"2024-11-09T00:00:00Z","timestamp":1731110400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-79166-9","type":"journal-article","created":{"date-parts":[[2024,11,9]],"date-time":"2024-11-09T14:15:06Z","timestamp":1731161706000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Increased serum EGF but not SDF-1 levels are associated with the pathophysiology and development of generalized anxiety disorder"],"prefix":"10.1038","volume":"14","author":[{"given":"A. S. M.","family":"Roknuzzaman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MMA Shalahuddin","family":"Qusar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Shahriar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sardar Mohammad","family":"Ashraful Islam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md. Rabiul","family":"Islam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,9]]},"reference":[{"key":"79166_CR1","doi-asserted-by":"publisher","unstructured":"Andrews, G. et al. Generalized worry disorder: a review of DSM-IV generalized anxiety disorder and options for DSM-V. Depress Anxiety. ;27(2):134\u2009\u2013\u200947. doi: (2010). https:\/\/doi.org\/10.1002\/da.20658. PMID: 20058241.","DOI":"10.1002\/da.20658"},{"key":"79166_CR2","volume-title":"Symptoms of generalized anxiety disorder among adults: United States, 2019","author":"EP Terlizzi","year":"2020","unstructured":"Terlizzi, E. P. & Villarroel, M. A. Symptoms of Generalized Anxiety Disorder among Adults: United States, 2019 (US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics, 2020). Sep 23."},{"key":"79166_CR3","doi-asserted-by":"publisher","unstructured":"Henning, E. R., Turk, C. L., Mennin, D. S., Fresco, D. M. & Heimberg, R. G. Impairment and quality of life in individuals with generalized anxiety disorder. Depress Anxiety. ;24(5):342-9. doi: (2007). https:\/\/doi.org\/10.1002\/da.20249. PMID: 17091478.","DOI":"10.1002\/da.20249"},{"issue":"8","key":"79166_CR4","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1016\/j.janxdis.2009.07.011","volume":"23","author":"TL Barrera","year":"2009","unstructured":"Barrera, T. L. & Norton, P. J. Quality of life impairment in generalized anxiety disorder, social phobia, and panic disorder. J. Anxiety Disord. 23 (8), 1086\u20131090. https:\/\/doi.org\/10.1016\/j.janxdis.2009.07.011 (2009). Epub 2009 Jul 14. PMID: 19640675; PMCID: PMC2782397.","journal-title":"J. Anxiety Disord"},{"issue":"5\u20136","key":"79166_CR5","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.cnr.2005.03.008","volume":"4","author":"J Kim","year":"2005","unstructured":"Kim, J. & Gorman, J. The psychobiology of anxiety. Clin. Neurosci. Res. 4 (5\u20136), 335\u2013347 (2005).","journal-title":"Clin. Neurosci. Res."},{"issue":"3","key":"79166_CR6","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.jad.2007.07.025","volume":"106","author":"I Chaudieu","year":"2008","unstructured":"Chaudieu, I. et al. Abnormal reactions to environmental stress in elderly persons with anxiety disorders: evidence from a population study of diurnal cortisol changes. J. Affect. Disord. 106 (3), 307\u2013313 (2008). Epub 2007 Aug 28. PMID: 17727959.","journal-title":"J. Affect. Disord"},{"issue":"2","key":"79166_CR7","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1080\/16506073.2014.888754","volume":"43","author":"K Fracalanza","year":"2014","unstructured":"Fracalanza, K., Koerner, N., Desch\u00eanes, S. S. & Dugas, M. J. Intolerance of uncertainty mediates the relation between generalized anxiety disorder symptoms and anger. Cogn. Behav. Ther. 43 (2), 122\u2013132 (2014). Epub 2014 Feb 28. PMID: 24579760.","journal-title":"Cogn. Behav. Ther."},{"issue":"3","key":"79166_CR8","doi-asserted-by":"publisher","first-page":"327","DOI":"10.31887\/DCNS.2015.17.3\/bbandelow","volume":"17","author":"B Bandelow","year":"2015","unstructured":"Bandelow, B. & Michaelis, S. Epidemiology of anxiety disorders in the 21st century. Dialogues Clin. Neurosci. 17 (3), 327\u2013335. https:\/\/doi.org\/10.31887\/DCNS.2015.17.3\/bbandelow (2015). PMID: 26487813; PMCID: PMC4610617.","journal-title":"Dialogues Clin. Neurosci."},{"issue":"10312","key":"79166_CR9","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1016\/S0140-6736(21)02143-7","volume":"398","author":"COVID-19 Mental Disorders Collaborators","year":"2021","unstructured":"COVID-19 Mental Disorders Collaborators. Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic. Lancet. 398 (10312), 1700\u20131712. https:\/\/doi.org\/10.1016\/S0140-6736(21)02143-7 (2021).","journal-title":"Lancet"},{"key":"79166_CR10","doi-asserted-by":"publisher","unstructured":"Kosel, M. et al. Diminished GABA(A) receptor-binding capacity and a DNA base substitution in a patient with treatment-resistant depression and anxiety. Neuropsychopharmacology. ;29(2):347\u2009\u2013\u200950. doi: (2004). https:\/\/doi.org\/10.1038\/sj.npp.1300353. Erratum in: Neuropsychopharmacology. 2004;29(9):1762. PMID: 14628001.","DOI":"10.1038\/sj.npp.1300353"},{"key":"79166_CR11","doi-asserted-by":"publisher","unstructured":"Jetty, P. V., Charney, D. S. & Goddard, A. W. Neurobiology of generalized anxiety disorder. Psychiatr Clin North Am. ;24(1):75\u201397. doi: (2001). https:\/\/doi.org\/10.1016\/s0193-953x(05)70207-0. PMID: 11225510.","DOI":"10.1016\/s0193-953x(05)70207-0"},{"key":"79166_CR12","doi-asserted-by":"crossref","unstructured":"Ressler, K. J. & Nemeroff, C. B. Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders. Depress Anxiety. ;12 Suppl 1:2\u201319. doi: 10.1002\/1520-6394 (2000) PMID: 11098410.","DOI":"10.1002\/1520-6394(2000)12:1+<2::AID-DA2>3.0.CO;2-4"},{"key":"79166_CR13","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.jad.2017.05.013","volume":"218","author":"JM Fitzgerald","year":"2017","unstructured":"Fitzgerald, J. M. et al. Prefrontal and amygdala engagement during emotional reactivity and regulation in generalized anxiety disorder. J. Affect. Disord. 218, 398\u2013406. https:\/\/doi.org\/10.1016\/j.jad.2017.05.013 (2017). Epub 2017 May 7. PMID: 28501740; PMCID: PMC6608590.","journal-title":"J. Affect. Disord"},{"issue":"1","key":"79166_CR14","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1186\/s12884-021-04225-2","volume":"21","author":"I Camacho-Arroyo","year":"2021","unstructured":"Camacho-Arroyo, I. et al. Chemokine profile in women with moderate to severe anxiety and depression during pregnancy. BMC Pregnancy Childbirth. 21 (1), 807. https:\/\/doi.org\/10.1186\/s12884-021-04225-2 (2021). PMID: 34863117; PMCID: PMC8642921.","journal-title":"BMC Pregnancy Childbirth"},{"key":"79166_CR15","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.psyneuen.2016.02.028","volume":"68","author":"M Bot","year":"2016","unstructured":"Bot, M., Milaneschi, Y., Penninx, B. W. & Drent, M. L. Plasma insulin-like growth factor I levels are higher in depressive and anxiety disorders, but lower in antidepressant medication users. Psychoneuroendocrinology. 68, 148\u2013155. https:\/\/doi.org\/10.1016\/j.psyneuen.2016.02.028 (2016). Epub 2016 Feb 27. PMID: 26974499.","journal-title":"Psychoneuroendocrinology"},{"key":"79166_CR16","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.psychres.2017.05.012","volume":"254","author":"AA Memon","year":"2017","unstructured":"Memon, A. A. et al. Role of IL-8, CRP and epidermal growth factor in depression and anxiety patients treated with mindfulness-based therapy or cognitive behavioral therapy in primary health care. Psychiatry Res. 254, 311\u2013316 (2017). Epub 2017 May 8. PMID: 28501736.","journal-title":"Psychiatry Res."},{"key":"79166_CR17","doi-asserted-by":"publisher","unstructured":"Pascual, M., Bali\u00f1o, P., Arag\u00f3n, C. M. & Guerri, C. Cytokines and chemokines as biomarkers of ethanol-induced neuroinflammation and anxiety-related behavior: role of TLR4 and TLR2. Neuropharmacology. ;89:352-9. doi: (2015). https:\/\/doi.org\/10.1016\/j.neuropharm.2014.10.014. PMID: 25446779.","DOI":"10.1016\/j.neuropharm.2014.10.014"},{"issue":"1","key":"79166_CR18","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.pharep.2014.08.006","volume":"67","author":"EA Og\u0142odek","year":"2015","unstructured":"Og\u0142odek, E. A., Szota, A. M., Just, M. J., Mo\u015b, D. M. & Araszkiewicz, A. The MCP-1, CCL-5 and SDF-1 chemokines as pro-inflammatory markers in generalized anxiety disorder and personality disorders. Pharmacol. Rep. 67 (1), 85\u201389 (2015). Epub 2014 Aug 21. PMID: 25560580.","journal-title":"Pharmacol. Rep."},{"key":"79166_CR19","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.bbi.2020.03.029","volume":"88","author":"M Murugan","year":"2020","unstructured":"Murugan, M. et al. Chemokine signaling mediated monocyte infiltration affects anxiety-like behavior following blast injury. Brain Behav. Immun. 88, 340\u2013352 (2020). Epub 2020 Mar 30. PMID: 32240765.","journal-title":"Brain Behav. Immun."},{"key":"79166_CR20","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.jad.2020.03.033","volume":"269","author":"C Roomruangwong","year":"2020","unstructured":"Roomruangwong, C., Sirivichayakul, S., Carvalho, A. F. & Maes, M. The uterine-chemokine-brain axis: menstrual cycle-associated symptoms (MCAS) are in part mediated by CCL2, CCL5, CCL11, CXCL8 and CXCL10. J. Affect. Disord. 269, 85\u201393 (2020). Epub 2020 Mar 19. PMID: 32217347.","journal-title":"J. Affect. Disord"},{"issue":"4","key":"79166_CR21","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/cmi.2017.107","volume":"15","author":"R Janssens","year":"2018","unstructured":"Janssens, R., Struyf, S. & Proost, P. The unique structural and functional features of CXCL12. Cell. Mol. Immunol. 15 (4), 299\u2013311. https:\/\/doi.org\/10.1038\/cmi.2017.107 (2018). Epub 2017 Oct 30. PMID: 29082918; PMCID: PMC6052832.","journal-title":"Cell. Mol. Immunol."},{"key":"79166_CR22","doi-asserted-by":"publisher","unstructured":"Yang, L. et al. Systemic inflammation induces anxiety disorder through CXCL12\/CXCR4 pathway. Brain Behav Immun. ;56:352\u2009\u2013\u200962. doi: (2016). https:\/\/doi.org\/10.1016\/j.bbi.2016.03.001. Epub 2016 Mar 4. PMID: 26952745.","DOI":"10.1016\/j.bbi.2016.03.001"},{"issue":"6","key":"79166_CR23","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.psyneuen.2008.03.002","volume":"33","author":"RC Mantella","year":"2008","unstructured":"Mantella, R. C. et al. Salivary cortisol is associated with diagnosis and severity of late-life generalized anxiety disorder. Psychoneuroendocrinology. 33 (6), 773\u2013781. https:\/\/doi.org\/10.1016\/j.psyneuen.2008.03.002 (2008). Epub 2008 Apr 14. PMID: 18407426; PMCID: PMC2766671.","journal-title":"Psychoneuroendocrinology"},{"key":"79166_CR24","doi-asserted-by":"publisher","unstructured":"Dalle Molle, R. et al. Associations between parenting behavior and anxiety in a rodent model and a clinical sample: relationship to peripheral BDNF levels. Transl Psychiatry. ;2(11):e195. doi: (2012). https:\/\/doi.org\/10.1038\/tp.2012.126. Erratum in: Transl Psychiatry. 2013;3:e225. Leistner-Segala, S [corrected to Leistner-Segal, S]. PMID: 23168995; PMCID: PMC3565759.","DOI":"10.1038\/tp.2012.126"},{"issue":"1","key":"79166_CR25","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.pnpbp.2006.09.006","volume":"31","author":"MC Jockers-Scher\u00fcbl","year":"2007","unstructured":"Jockers-Scher\u00fcbl, M. C. et al. Nerve growth factor serum concentrations rise after successful cognitive-behavioural therapy of generalized anxiety disorder. Prog Neuropsychopharmacol. Biol. Psychiatry. 31 (1), 200\u2013204. https:\/\/doi.org\/10.1016\/j.pnpbp.2006.09.006 (2007). Epub 2006 Oct 20. PMID: 17055636.","journal-title":"Prog Neuropsychopharmacol. Biol. Psychiatry"},{"key":"79166_CR26","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.cytogfr.2016.08.004","volume":"32","author":"AY Galvez-Contreras","year":"2016","unstructured":"Galvez-Contreras, A. Y. et al. Growth factors as clinical biomarkers of prognosis and diagnosis in psychiatric disorders. Cytokine Growth Factor. Rev. 32, 85\u201396 (2016). Epub 2016 Sep 8. PMID: 27618303.","journal-title":"Cytokine Growth Factor. Rev."},{"issue":"1","key":"79166_CR27","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s13104-020-04952-3","volume":"13","author":"MPZ Emon","year":"2020","unstructured":"Emon, M. P. Z. et al. Reduced serum BDNF levels are associated with the increased risk for developing MDD: a case-control study with or without antidepressant therapy. BMC Res. Notes. 13 (1), 83. https:\/\/doi.org\/10.1186\/s13104-020-04952-3 (2020). PMID: 32085720; PMCID: PMC7035767.","journal-title":"BMC Res. Notes"},{"key":"79166_CR28","doi-asserted-by":"publisher","unstructured":"Gioiosa, L., Iannitelli, A. & Aloe, L. Stress, anxiety and schizophrenia and neurotrophic factors: the pioneer studies with nerve growth factor. Riv Psichiatr. doi: (2009). Mar-Apr;44(2):88\u201394 https:\/\/doi.org\/10.1708\/420.4978. PMID: 20066809.","DOI":"10.1708\/420.4978"},{"key":"79166_CR29","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3389\/fnbeh.2017.00091","volume":"11","author":"K Poon","year":"2017","unstructured":"Poon, K., Barson, J. R., Shi, H., Chang, G. Q. & Leibowitz, S. F. Involvement of the CXCL12 system in the Stimulatory effects of prenatal exposure to High-Fat Diet on hypothalamic orexigenic peptides and behavior in offspring. Front. Behav. Neurosci. 11, 91. https:\/\/doi.org\/10.3389\/fnbeh.2017.00091 (2017). PMID: 28567007; PMCID: PMC5434113.","journal-title":"Front. Behav. Neurosci."},{"key":"79166_CR30","doi-asserted-by":"publisher","unstructured":"Herbst, R. S. Review of epidermal growth factor receptor biology. Int J Radiat Oncol Biol Phys. ;59(2 Suppl):21\u2009\u2013\u20096. doi: (2004). https:\/\/doi.org\/10.1016\/j.ijrobp.2003.11.041. PMID: 15142631.","DOI":"10.1016\/j.ijrobp.2003.11.041"},{"issue":"7","key":"79166_CR31","doi-asserted-by":"publisher","first-page":"2484","DOI":"10.3390\/ijms21072484","volume":"21","author":"K Sanada","year":"2020","unstructured":"Sanada, K. et al. Effects of Mindfulness-based interventions on biomarkers and low-Grade inflammation in patients with Psychiatric disorders: a Meta-Analytic Review. Int. J. Mol. Sci. 21 (7), 2484. https:\/\/doi.org\/10.3390\/ijms21072484 (2020). PMID: 32260096; PMCID: PMC7177919.","journal-title":"Int. J. Mol. Sci."},{"key":"79166_CR32","doi-asserted-by":"publisher","unstructured":"Duffy, L., Cappas, E., Scimone, A., Schofield, P. R. & Karl, T. Behavioral profile of a heterozygous mutant mouse model for EGF-like domain neuregulin 1. Behav Neurosci. ;122(4):748\u2009\u2013\u200959. doi: (2008). https:\/\/doi.org\/10.1037\/0735-7044.122.4.748. PMID: 18729627.","DOI":"10.1037\/0735-7044.122.4.748"},{"key":"79166_CR33","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.jconrel.2020.03.027","volume":"322","author":"H He","year":"2020","unstructured":"He, H. et al. An in vitro and in vivo study of the brain-targeting effects of an epidermal growth factor-functionalized cholera toxin-like chimeric protein. J. Control Release. 322, 509\u2013518 (2020). Epub 2020 Mar 20. PMID: 32205153.","journal-title":"J. Control Release"},{"key":"79166_CR34","doi-asserted-by":"publisher","unstructured":"Stein, M. B. & Sareen, J. CLINICAL PRACTICE. Generalized Anxiety Disorder. N Engl J Med. ;373(21):2059-68. doi: (2015). https:\/\/doi.org\/10.1056\/NEJMcp1502514. PMID: 26580998.","DOI":"10.1056\/NEJMcp1502514"},{"key":"79166_CR35","unstructured":"Munir, S., Takov, V. & Publishing, L. L. C. Generalized anxiety disorder [Internet]. StatPearls [cited 2023 May 21]. (2022). https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK441870\/"},{"issue":"12","key":"79166_CR36","doi-asserted-by":"publisher","first-page":"e0261590","DOI":"10.1371\/journal.pone.0261590","volume":"16","author":"TA Dhira","year":"2021","unstructured":"Dhira, T. A., Rahman, M. A., Sarker, A. R. & Mehareen, J. Validity and reliability of the generalized anxiety Disorder-7 (GAD-7) among university students of Bangladesh. PLoS One. 16 (12), e0261590. https:\/\/doi.org\/10.1371\/journal.pone.0261590 (2021). Published 2021 Dec 16.","journal-title":"PLoS One"},{"issue":"7","key":"79166_CR37","doi-asserted-by":"publisher","first-page":"e0288159","DOI":"10.1371\/journal.pone.0288159","volume":"18","author":"M Sohan","year":"2023","unstructured":"Sohan, M. et al. Association of reduced serum EGF and leptin levels with the pathophysiology of major depressive disorder: a case-control study. PLoS One. 18 (7), e0288159. https:\/\/doi.org\/10.1371\/journal.pone.0288159 (2023). PMID: 37399205; PMCID: PMC10317226.","journal-title":"PLoS One"},{"key":"79166_CR38","doi-asserted-by":"publisher","first-page":"204512532091665","DOI":"10.1177\/2045125320916655","volume":"10","author":"S Anjum","year":"2020","unstructured":"Anjum, S. et al. Altered serum interleukin-7 and interleukin-10 are associated with drug-free major depressive disorder. Ther. Adv. Psychopharmacol. 10, 2045125320916655. https:\/\/doi.org\/10.1177\/2045125320916655 (2020). PMID: 32435448; PMCID: PMC7225792.","journal-title":"Ther. Adv. Psychopharmacol."},{"key":"79166_CR39","doi-asserted-by":"publisher","first-page":"205031212097416","DOI":"10.1177\/2050312120974169","volume":"8","author":"S Daria","year":"2020","unstructured":"Daria, S. et al. Serum interferon-gamma level is associated with drug-na\u00efve major depressive disorder. SAGE Open. Med. 8, 2050312120974169. https:\/\/doi.org\/10.1177\/2050312120974169 (2020). PMID: 33282305; PMCID: PMC7682211.","journal-title":"SAGE Open. Med."},{"issue":"11","key":"79166_CR40","doi-asserted-by":"publisher","first-page":"e6081","DOI":"10.7759\/cureus.6081","volume":"11","author":"R Das","year":"2019","unstructured":"Das, R. et al. Evaluation of serum glial cell line-derived neurotrophic factor in Bangladeshi major depressive disorder patients. Cureus. 11 (11), e6081. https:\/\/doi.org\/10.7759\/cureus.6081 (2019). PMID: 31853432; PMCID: PMC6894901.","journal-title":"Cureus"},{"key":"79166_CR41","doi-asserted-by":"publisher","unstructured":"I\u015feri, E. et al. Increased serum levels of epidermal growth factor in children with autism. J Autism Dev Disord. ;41(2):237\u2009\u2013\u200941. doi: (2011). https:\/\/doi.org\/10.1007\/s10803-010-1046-3. PMID: 20544265.","DOI":"10.1007\/s10803-010-1046-3"},{"key":"79166_CR42","doi-asserted-by":"publisher","unstructured":"Ali, S. et al. Serum insulin-like growth factor-1 and relaxin-3 are linked with major depressive disorder. Asian J Psychiatr. ;53:102164. doi: (2020). https:\/\/doi.org\/10.1016\/j.ajp.2020.102164. Epub 2020 May 11. PMID: 32446216.","DOI":"10.1016\/j.ajp.2020.102164"},{"issue":"2","key":"79166_CR43","doi-asserted-by":"publisher","first-page":"470","DOI":"10.3390\/antiox12020470","volume":"12","author":"AS Correia","year":"2023","unstructured":"Correia, A. S., Cardoso, A. & Vale, N. Oxidative stress in Depression: the link with the stress response, neuroinflammation, serotonin, neurogenesis and synaptic plasticity. Antioxid. (Basel). 12 (2), 470. https:\/\/doi.org\/10.3390\/antiox12020470 (2023). PMID: 36830028; PMCID: PMC9951986.","journal-title":"Antioxid. (Basel)"},{"issue":"6","key":"79166_CR44","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3109\/10253891003743432","volume":"13","author":"I Fatouros","year":"2010","unstructured":"Fatouros, I. et al. Acute resistance exercise results in catecholaminergic rather than hypothalamic-pituitary-adrenal axis stimulation during exercise in young men. Stress. 13 (6), 461\u2013468. https:\/\/doi.org\/10.3109\/10253891003743432 (2010). Epub 2010 Jul 28. PMID: 20666650.","journal-title":"Stress"},{"issue":"1","key":"79166_CR45","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1186\/s12888-024-05911-z","volume":"24","author":"N Sarmin","year":"2024","unstructured":"Sarmin, N. et al. Association of interleukin-2 and interleukin-10 with the pathophysiology and development of generalized anxiety disorder: a case-control study. BMC Psychiatry. 24 (1), 462. https:\/\/doi.org\/10.1186\/s12888-024-05911-z (2024). Published 2024 Jun 20.","journal-title":"BMC Psychiatry"},{"issue":"2","key":"79166_CR46","doi-asserted-by":"publisher","first-page":"370","DOI":"10.9758\/cpn.2023.21.2.370","volume":"21","author":"O Hursito\u011flu","year":"2023","unstructured":"Hursito\u011flu, O. & Kurutas, E. B. Serum levels of 8-Iso-prostaglandin F2\u03b1 and Raftlin in patients with generalized anxiety disorder. Clin. Psychopharmacol. Neurosci. 21 (2), 370\u2013376. https:\/\/doi.org\/10.9758\/cpn.2023.21.2.370 (2023).","journal-title":"Clin. Psychopharmacol. Neurosci."},{"issue":"8","key":"79166_CR47","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.3390\/jcm10081744","volume":"10","author":"K \u0141o\u015b","year":"2021","unstructured":"\u0141o\u015b, K. & Waszkiewicz, N. Biological markers in anxiety disorders. J. Clin. Med. 10 (8), 1744. https:\/\/doi.org\/10.3390\/jcm10081744 (2021). Published 2021 Apr 17.","journal-title":"J. Clin. Med."},{"issue":"18","key":"79166_CR48","doi-asserted-by":"publisher","first-page":"6546","DOI":"10.3390\/ijms21186546","volume":"21","author":"E Won","year":"2020","unstructured":"Won, E. & Kim, Y. K. Neuroinflammation-Associated alterations of the brain as potential neural biomarkers in anxiety disorders. Int. J. Mol. Sci. 21 (18), 6546. https:\/\/doi.org\/10.3390\/ijms21186546 (2020). Published 2020 Sep 7.","journal-title":"Int. J. Mol. Sci."},{"key":"79166_CR49","doi-asserted-by":"publisher","unstructured":"Chrousos, G. P. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med. ;332(20):1351-62. doi: (1995). https:\/\/doi.org\/10.1056\/NEJM199505183322008. PMID: 7715646.","DOI":"10.1056\/NEJM199505183322008"},{"key":"79166_CR50","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.neulet.2014.12.064","volume":"589","author":"JW Kim","year":"2015","unstructured":"Kim, J. W. et al. Diagnostic utility of quantitative EEG in un-medicated schizophrenia. Neurosci. Lett. 589, 126\u2013131. https:\/\/doi.org\/10.1016\/j.neulet.2014.12.064 (2015). Epub 2015 Jan 13. PMID: 25595562.","journal-title":"Neurosci. Lett."},{"issue":"7","key":"79166_CR51","doi-asserted-by":"publisher","first-page":"e67579","DOI":"10.1371\/journal.pone.0067579","volume":"8","author":"H Rundqvist","year":"2013","unstructured":"Rundqvist, H. et al. Effect of acute exercise on prostate cancer cell growth. PLoS One. 8 (7), e67579. https:\/\/doi.org\/10.1371\/journal.pone.0067579 (2013). PMID: 23861774; PMCID: PMC3702495.","journal-title":"PLoS One"},{"key":"79166_CR52","doi-asserted-by":"publisher","first-page":"881241","DOI":"10.3389\/fpsyt.2022.881241","volume":"13","author":"Z Shen","year":"2022","unstructured":"Shen, Z. et al. Combining S100B and cytokines as neuro-inflammatory biomarkers for diagnosing generalized anxiety disorder: a proof-of-Concept Study based on machine learning. Front. Psychiatry. 13, 881241. https:\/\/doi.org\/10.3389\/fpsyt.2022.881241 (2022). Published 2022 Jun 22.","journal-title":"Front. Psychiatry"},{"issue":"1","key":"79166_CR53","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/npp.2016.146","volume":"42","author":"V Michopoulos","year":"2017","unstructured":"Michopoulos, V., Powers, A., Gillespie, C. F., Ressler, K. J. & Jovanovic, T. Inflammation in fear- and anxiety-based disorders: PTSD, GAD, and Beyond. Neuropsychopharmacology. 42 (1), 254\u2013270. https:\/\/doi.org\/10.1038\/npp.2016.146 (2017).","journal-title":"Neuropsychopharmacology"},{"key":"79166_CR54","doi-asserted-by":"publisher","first-page":"100024","DOI":"10.1016\/j.bionps.2020.100024","volume":"3","author":"JR Strawn","year":"2020","unstructured":"Strawn, J. R. & Levine, A. Treatment response biomarkers in anxiety disorders: from neuroimaging to Neuronally-Derived Extracellular vesicles and Beyond. Biomark. Neuropsychiatry. 3, 100024. https:\/\/doi.org\/10.1016\/j.bionps.2020.100024 (2020).","journal-title":"Biomark. Neuropsychiatry"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-79166-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-79166-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-79166-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T19:03:01Z","timestamp":1731438181000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-79166-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,9]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["79166"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-79166-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,9]]},"assertion":[{"value":"1 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"27409"}}